Log in
Enquire now
‌

US Patent 7713293 Transverse suspension device

Patent 7713293 was granted and assigned to ArthroCare on May, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Patent abstractTimelineTable: Further ResourcesReferences
Is a
Patent
Patent
1

Patent attributes

Current Assignee
‌
ArthroCare
1
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
77132931
Patent Inventor Names
Simon David Mifsud1
Agostino Tucciarone1
Date of Patent
May 11, 2010
1
Patent Application Number
108221011
Date Filed
April 8, 2004
1
Patent Primary Examiner
‌
Eduardo C Robert
1
Patent abstract

A transverse suspension device for ACL graft fixation in a femoral tunnel includes a body section and a smooth head section forming the leading end of the device. The body and smooth head sections each may be cannulated along their entire lengths. The head section may further include a recess-engaging section extending proximally from the distal end and is operable to engage with a recess formed in the bone tunnel. The device may further include a graft loop support section between the recess-engaging section and the body section adapted to stably support the graft loop.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7713293 Transverse suspension device

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.